[unable to retrieve full-text content]
Drug distributor backs fiscal 2024 profit guidance despite end of contract that generated 16% of its revenue last year.
[unable to retrieve full-text content]
Drug distributor backs fiscal 2024 profit guidance despite end of contract that generated 16% of its revenue last year.
Brainfind is your one-stop shop for breaking news headlines and personalized news stories. Not only are we a news aggregator and content curator, we also allow registered users to publish their own articles on our website with full credit and their social links.